Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices

被引:71
|
作者
Skene, DJ [1 ]
Papagiannidou, E [1 ]
Hashemi, E [1 ]
Snelling, J [1 ]
Lewis, DFV [1 ]
Fernandez, M [1 ]
Ioannides, C [1 ]
机构
[1] Univ Surrey, Sch Biol Sci, Guildford GU2 5XH, Surrey, England
关键词
CYP1A2; cytochrome P450; enzyme induction; liver slices; melatonin; 6-sulphatoxymelatonin;
D O I
10.1034/j.1600-079X.2001.310408.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of the present studies was to define the enzyme systems catalysing the 6-hydroxylation of melatonin, by monitoring the levels of 6-sulphatoxymelatonin in rat hepatic postmitochondrial preparations and in precision-cut liver slices. Melatonin 6-hydroxylase activity was localized in microsomes and was supported by NADPH, but not NADH. Treatment of rats with beta -naphthoflavone more than tripled 6-sulphatoxymelatonin formation from melatonin, but gave rise only to a moderate increase (25%) in the sulphate conjugation of 6-hydroxymelatonin. Treatment of rats with phenobarbitone, acetone, dexamethasone and clofibrate did not increase 6-sulphatoxymelatonin generation when either melatonin or 6-hydroxymelatonin served as substrates. Of a number of cytochrome P450 inhibitors investigated, only furafylline inhibited markedly the conversion of melatonin to 6-sulphatoxymelatonin without any concomitant effect on the sulphoconjugation of 6-hydroxymelatonin. When liver slices were incubated with melatonin, treatment of rats with beta -naphthoflavone, and to a lesser extent phenobarbitone. elevated the levels of 6-sulphatoxymelatonin in the culture medium. No such increase was seen when slices from beta -naphthoflavone-treated rats were incubated with 6-hydroxymelatonin, whereas a modest increase was seen with slices from phenobarbitone-treated rats. Treatment of rats with acetone, dexamethasone or clofibrate railed to modulate the levels of 6-sulphatoxymelatonin generated from either melatonin or 6-hydroxymetatonin. Molecular modelling analysis revealed that melatonin had a high area/depth(2) ratio, displayed characteristics of CYP1A2 substrates and could be readily accommodated into the human CYP1A2 active site in a position favouring 6-hydroxylation. Collectively, all the above data provide strong experimental evidence that CYP1A2 is an important catalyst of the 6-hydroxylation of melatonin.
引用
收藏
页码:333 / 342
页数:10
相关论文
共 50 条
  • [1] Evidence supporting the interaction of CYP2B4 and CYP1A2 in microsomal preparations
    Cawley, GF
    Zhang, SX
    Kelley, RW
    Backes, WL
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (12) : 1529 - 1534
  • [2] COMPARISON OF RAT HEPATIC MICROSOMAL MIXED-FUNCTION OXIDASE ACTIVITIES IN MICROSOMAL PREPARATIONS, ISOLATED HEPATOCYTES AND LIVER SLICES
    GERAYESHNEJAD, S
    JONES, RS
    PARKE, DV
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1975, 3 (03) : 403 - 405
  • [3] Not only CYP1A2 but also CYP1B1 is involved in the metabolism of melatonin
    Roos, PH
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R106 - R106
  • [4] Role of CYP1A2 in caffeine pharmacokinetics and metabolism: Studies using mice deficient in CYP1A2
    Buters, JTM
    Tang, BK
    Pineau, T
    Gelboin, HV
    Kimura, S
    Gonzalez, FJ
    PHARMACOGENETICS, 1996, 6 (04): : 291 - 296
  • [5] Involvement of human liver CYP1A2 in the metabolism of propofol
    Oda, Y
    Hamaoka, N
    Hase, I
    Tanaka, K
    Asada, A
    ANESTHESIOLOGY, 1999, 91 (3A) : U244 - U244
  • [6] ESTROGEN METABOLISM IN RAT-LIVER MICROSOMAL AND ISOLATED HEPATOCYTE PREPARATIONS .2. INHIBITION STUDIES
    BRUEGGEMEIER, RW
    KIMBALL, JG
    KRAFT, F
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 21 (06): : 709 - 716
  • [7] Role of CYP1A2 in hepatic sequestration of dioxin: Studies using CYP1A2 knock-out mice
    Diliberto, JJ
    Burgin, D
    Birnbaum, LS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) : 431 - 433
  • [8] Evidence for the involvement of CYP1A2 in the metabolism of bromodichloromethane in rat liver
    Allis, JW
    Anderson, BP
    Zhao, GY
    Ross, TM
    Pegram, RA
    TOXICOLOGY, 2002, 176 (1-2) : 25 - 37
  • [9] Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice
    Kapelyukh, Y.
    Henderson, C. J.
    Scheer, N.
    Rode, A.
    Wolf, C. R.
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (08) : 907 - 918
  • [10] Effect of in utero exposure to coplanar PCBs on the liver microsomal CYP1A1 and CYP1A2 levels in the rat
    Akahori, F
    Shirai, M
    Iki, Y
    Ito, T
    Orito, K
    TOXICOLOGY, 2001, 164 (1-3) : 145 - 146